Explaining his decision to grant clemency to the financier Michael Milken, President Trump spoke thus:
“We have Mike Milken, who’s gone around and done an incredible job for the world, with all of his research on cancer, and he’s done this, and he suffered greatly. He paid a big price; paid a very tough price. But he’s done an incredible job.”
Milken, 73, is an outsized, polarizing figure, but regardless of whether you are a detractor or an admirer, intellectual honesty dictates acknowledging his key role in setting a more aggressive pace in cancer research over the past quarter-century.
This is an excerpt of an article that was published in full in The Cancer Letter.
Vol. 46 No. 08 | February 21, 2020
